$EXEL
EXELIXIS, INC. Stock $exel

$exel Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 10-K Financial Statement

#000093976715000013 Filed on March 02, 2015

Income Statement

Concept	2015 Q1	2014	2013 Q4
Revenue	$9.388M	$25.11M	$4.347M
YoY Change	91.4%	-19.87%	-44.37%
Cost Of Revenue	$766.0K	$2.043M	$300.0K
YoY Change	147.9%	82.74%
Gross Profit	$8.622M	$23.07M	$4.084M
YoY Change	87.6%	-23.67%
Gross Profit Margin	91.84%	91.86%	93.95%
Selling, General & Admin	$9.531M	$50.83M	$13.60M
YoY Change	-35.12%	-0.25%	38.78%
% of Gross Profit	110.54%	220.34%	333.01%
Research & Development	$22.28M	$189.1M	$49.60M
YoY Change	-59.37%	5.78%	52.62%
% of Gross Profit	258.43%	819.75%	1214.5%
Depreciation & Amortization	$297.0K	$2.391M	$700.0K
YoY Change	-40.36%	-24.02%	-50.0%
% of Gross Profit	3.44%	10.37%	17.14%
Operating Expenses	$32.15M	$249.6M	$63.30M
YoY Change	-54.0%	7.54%	49.65%
Operating Profit	-$22.76M	-$224.5M	-$59.22M
YoY Change	-64.98%	11.82%
Interest Expense	$12.40M	$41.36M	-$11.30M
YoY Change	5.45%	6.66%	11.88%
% of Operating Profit
Other Income/Expense, Net	-$12.41M	-$37.02M
YoY Change	28.85%	-1.42%
Pretax Income	-$35.20M	-$230.5M	-$70.80M
YoY Change	-52.82%	-2.35%	35.89%
Income Tax		-$182.0K	-$100.0K
% Of Pretax Income
Net Earnings	-$33.25M	-$261.3M	-$70.75M
YoY Change	-55.45%	9.7%	35.55%
Net Earnings / Revenue	-354.12%	-1040.57%	-1627.47%
Basic Earnings Per Share
Diluted Earnings Per Share	-$179.7K	-$1.345M	-$383.4K
COMMON SHARES
Basic Shares Outstanding	195.9M shares		184.2M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q1	2014	2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$107.2M	$144.3M	$242.5M
YoY Change	-60.82%	-40.49%	-41.05%
Cash & Equivalents	$80.40M	$80.40M	$104.0M
Short-Term Investments	$22.30M	$63.90M	$138.5M
Other Short-Term Assets	$11.30M	$15.70M	$17.30M
YoY Change	-35.8%	-9.25%	-5.46%
Inventory	$2.593M	$2.400M	$2.890M
Prepaid Expenses
Receivables	$3.900M	$4.900M	$3.900M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$125.0M	$167.2M	$266.6M
YoY Change	-58.08%	-37.28%	-38.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.158M	$2.400M	$4.910M
YoY Change	-53.94%	-51.02%	-18.96%
Goodwill	$63.68M		$63.68M
YoY Change	0.0%		0.0%
Intangibles
YoY Change
Long-Term Investments	$81.60M	$81.60M	$144.3M
YoY Change	-26.62%	-43.45%	-20.84%
Other Assets	$7.771M	$8.300M	$6.888M
YoY Change	-12.86%	-65.13%	-19.33%
Total Long-Term Assets	$157.9M	$156.1M	$236.7M
YoY Change	-20.76%	-34.05%	-17.98%
TOTAL ASSETS
Total Short-Term Assets	$125.0M	$167.2M	$266.6M
Total Long-Term Assets	$157.9M	$156.1M	$236.7M
Total Assets	$282.9M	$323.3M	$503.3M
YoY Change	-43.14%	-35.76%	-30.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.303M	$6.400M	$9.345M
YoY Change	-73.64%	-31.18%	112.48%
Accrued Expenses	$30.98M	$57.20M	$34.96M
YoY Change	-20.81%	-6.08%	70.03%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.075M	$97.80M	$11.76M
YoY Change	192.74%	728.81%	-10.69%
Total Short-Term Liabilities	$58.68M	$170.4M	$87.85M
YoY Change	-17.42%	93.86%	7.53%
LONG-TERM LIABILITIES
Long-Term Debt	$364.4M	$259.1M	$335.5M
YoY Change	6.65%	-22.77%	4.0%
Other Long-Term Liabilities	$2.961M	$8.500M	$4.674M
YoY Change	-45.84%	-37.96%	-25.29%
Total Long-Term Liabilities	$367.3M	$267.6M	$340.1M
YoY Change	5.83%	-23.37%	3.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$58.68M	$170.4M	$87.85M
Total Long-Term Liabilities	$367.3M	$267.6M	$340.1M
Total Liabilities	$429.7M	$438.1M	$483.5M
YoY Change	0.85%	0.25%	1.56%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.802B		-$1.490B
YoY Change	14.56%		19.03%
Common Stock	$196.0K		$184.0K
YoY Change	1.03%		0.55%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$146.8M	-$114.8M	$66.20M
YoY Change
Total Liabilities & Shareholders Equity	$282.9M	$323.3M	$503.3M
YoY Change	-43.14%	-35.76%	-30.21%

Cashflow Statement

Concept	2015 Q1	2014	2013 Q4
OPERATING ACTIVITIES
Net Income	-$33.25M	-$261.3M	-$70.75M
YoY Change	-55.45%	9.7%	35.55%
Depreciation, Depletion And Amortization	$297.0K	$2.391M	$700.0K
YoY Change	-40.36%	-24.02%	-50.0%
Cash From Operating Activities	-$45.09M	-$235.4M	-$47.40M
YoY Change	-37.46%	18.43%	22.48%
INVESTING ACTIVITIES
Capital Expenditures	$31.00K	$474.0K	-$100.0K
YoY Change	-91.93%	-78.17%	-91.67%
Acquisitions
YoY Change
Other Investing Activities	$49.90M	$146.8M	$59.60M
YoY Change	-17.79%	0.2%	-160.51%
Cash From Investing Activities	$49.90M	$146.3M	$59.60M
YoY Change	-17.34%	1.37%	-159.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$75.64M
YoY Change	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$217.0K	$65.49M	-200.0K
YoY Change	-100.33%	-661.25%	-50.0%
NET CHANGE
Cash From Operating Activities	-$45.09M	-$235.4M	-47.40M
Cash From Investing Activities	$49.90M	$146.3M	59.60M
Cash From Financing Activities	-$217.0K	$65.49M	-200.0K
Net Change In Cash	$4.592M	-$23.58M	12.00M
YoY Change	-91.43%	-64.32%	-108.65%
FREE CASH FLOW
Cash From Operating Activities	-$45.09M	-$235.4M	-$47.40M
Capital Expenditures	$31.00K	$474.0K	-$100.0K
Free Cash Flow	-$45.12M	-$235.9M	-$47.30M
YoY Change	-37.74%	17.39%	26.13%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014	dei	Amendment Flag AmendmentFlag	false
CY2014	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-02
CY2014	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2014	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014	dei	Document Period End Date DocumentPeriodEndDate	2015-01-02
CY2014	dei	Document Type DocumentType	10-K
CY2014	dei	Entity Central Index Key EntityCentralIndexKey	0000939767
CY2015Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	195895769	shares
CY2014	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2014	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2014Q2	dei	Entity Public Float EntityPublicFloat	665606336	USD
CY2014	dei	Entity Registrant Name EntityRegistrantName	EXELIXIS, INC.
CY2014	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2014	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2014	dei	Trading Symbol TradingSymbol	exel
CY2012	exel	Annual Operating Cycle AnnualOperatingCycle	P364D
CY2013	exel	Annual Operating Cycle AnnualOperatingCycle	P364D
CY2014	exel	Annual Operating Cycle AnnualOperatingCycle	P371D
CY2013Q4	exel	Cash Cash Equivalentsand Availableforsale Securities CashCashEquivalentsandAvailableforsaleSecurities	415862000	USD
CY2014Q4	exel	Cash Cash Equivalentsand Availableforsale Securities CashCashEquivalentsandAvailableforsaleSecurities	242760000	USD
CY2013Q4	exel	Cash Cash Equivalentsand Availableforsale Securities Amortized Cost Basis CashCashEquivalentsandAvailableforsaleSecuritiesAmortizedCostBasis	415617000	USD
CY2014Q4	exel	Cash Cash Equivalentsand Availableforsale Securities Amortized Cost Basis CashCashEquivalentsandAvailableforsaleSecuritiesAmortizedCostBasis	242772000	USD
CY2013Q4	exel	Cash Cash Equivalentsand Availableforsale Securities Gross Unrealized Gain Accumulatedin Investments CashCashEquivalentsandAvailableforsaleSecuritiesGrossUnrealizedGainAccumulatedinInvestments	300000	USD
CY2014Q4	exel	Cash Cash Equivalentsand Availableforsale Securities Gross Unrealized Gain Accumulatedin Investments CashCashEquivalentsandAvailableforsaleSecuritiesGrossUnrealizedGainAccumulatedinInvestments	145000	USD
CY2013Q4	exel	Cash Cash Equivalentsand Availableforsale Securities Gross Unrealized Loss Accumulatedin Investments CashCashEquivalentsandAvailableforsaleSecuritiesGrossUnrealizedLossAccumulatedinInvestments	55000	USD
CY2014Q4	exel	Cash Cash Equivalentsand Availableforsale Securities Gross Unrealized Loss Accumulatedin Investments CashCashEquivalentsandAvailableforsaleSecuritiesGrossUnrealizedLossAccumulatedinInvestments	157000	USD
CY2013Q4	exel	Collateral Provided For Purchasing Card Program CollateralProvidedForPurchasingCardProgram	3500000	USD
CY2014Q4	exel	Collateral Provided For Purchasing Card Program CollateralProvidedForPurchasingCardProgram	3500000	USD
CY2013Q4	exel	Computer Equipment And Software ComputerEquipmentAndSoftware	14462000	USD
CY2014Q4	exel	Computer Equipment And Software ComputerEquipmentAndSoftware	14840000	USD
CY2010Q2	exel	Debt Collateral Number Of Affiliate Banks DebtCollateralNumberOfAffiliateBanks	1	affiliate
CY2014	exel	Debt Collateral Number Of Affiliate Banks DebtCollateralNumberOfAffiliateBanks	1	affiliate
CY2014	exel	Debt Collateral Number Of Required Investment Accounts DebtCollateralNumberOfRequiredInvestmentAccounts	1	account
CY2013Q4	exel	Deferred Tax Assets Amortization Of Deferred Stock Compensation Non Qualified DeferredTaxAssetsAmortizationOfDeferredStockCompensationNonQualified	24279000	USD
CY2014Q4	exel	Deferred Tax Assets Amortization Of Deferred Stock Compensation Non Qualified DeferredTaxAssetsAmortizationOfDeferredStockCompensationNonQualified	27500000	USD
CY2013Q4	exel	Deferred Tax Assets Book Over Tax Depreciation DeferredTaxAssetsBookOverTaxDepreciation	4499000	USD
CY2014Q4	exel	Deferred Tax Assets Book Over Tax Depreciation DeferredTaxAssetsBookOverTaxDepreciation	5118000	USD
CY2014	exel	Defined Benefit Plan Contributions By Employer For First Four Percent Of Participant Contributions DefinedBenefitPlanContributionsByEmployerForFirstFourPercentOfParticipantContributions	0.5
CY2014	exel	Defined Benefit Plan Contributions By Employer For First Three Percent Of Participant Contributions DefinedBenefitPlanContributionsByEmployerForFirstThreePercentOfParticipantContributions	1
CY2012	exel	Effective Income Tax Rate Reconciliation Deduction Afs Securities EffectiveIncomeTaxRateReconciliationDeductionAFSSecurities	0	USD
CY2013	exel	Effective Income Tax Rate Reconciliation Deduction Afs Securities EffectiveIncomeTaxRateReconciliationDeductionAFSSecurities	106000	USD
CY2014	exel	Effective Income Tax Rate Reconciliation Deduction Afs Securities EffectiveIncomeTaxRateReconciliationDeductionAFSSecurities	0	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	46270000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	146000	USD
CY2012	exel	Effective Income Tax Rate Reconciliation Deduction Ip Transfer EffectiveIncomeTaxRateReconciliationDeductionIPTransfer	0	USD
CY2013	exel	Effective Income Tax Rate Reconciliation Deduction Ip Transfer EffectiveIncomeTaxRateReconciliationDeductionIPTransfer	82858000	USD
CY2014	exel	Effective Income Tax Rate Reconciliation Deduction Ip Transfer EffectiveIncomeTaxRateReconciliationDeductionIPTransfer	0	USD
CY2012	exel	Gain Loss On Sale Of Impaired Property Plant Equipment GainLossOnSaleOfImpairedPropertyPlantEquipment	300000	USD
CY2013	exel	Gain Loss On Sale Of Impaired Property Plant Equipment GainLossOnSaleOfImpairedPropertyPlantEquipment	0	USD
CY2014	exel	Gain Loss On Sale Of Impaired Property Plant Equipment GainLossOnSaleOfImpairedPropertyPlantEquipment	600000	USD
CY2012	exel	Income Tax Reconciliation Unutilized Net Operating Losses IncomeTaxReconciliationUnutilizedNetOperatingLosses	46324000	USD
CY2013	exel	Income Tax Reconciliation Unutilized Net Operating Losses IncomeTaxReconciliationUnutilizedNetOperatingLosses	-3438000	USD
CY2014	exel	Income Tax Reconciliation Unutilized Net Operating Losses IncomeTaxReconciliationUnutilizedNetOperatingLosses	87448000	USD
CY2013Q4	exel	Laboratory Equipment LaboratoryEquipment	15453000	USD
CY2014Q4	exel	Laboratory Equipment LaboratoryEquipment	13677000	USD
CY2012	exel	License Contractand Collaboration Reimbursement Revenue LicenseContractandCollaborationReimbursementRevenue	47450000	USD
CY2013	exel	License Contractand Collaboration Reimbursement Revenue LicenseContractandCollaborationReimbursementRevenue	16321000	USD
CY2014	exel	License Contractand Collaboration Reimbursement Revenue LicenseContractandCollaborationReimbursementRevenue	0	USD
CY2014Q4	exel	Maximum Potential Milestone Payments MaximumPotentialMilestonePayments	2300000000	USD
CY2014Q4	exel	Numberof Phase3 Trialsin Process NumberofPhase3TrialsinProcess	2	phase
CY2014Q4	exel	Numberof Trialsin Process NumberofTrialsinProcess	45	trial
CY2014Q4	exel	Operating Leases Material Future Minimum Payments Due OperatingLeasesMaterialFutureMinimumPaymentsDue	48493000	USD
CY2014	exel	Percentage Of Employers Match Towards Employees Contribution PercentageOfEmployersMatchTowardsEmployeesContribution	0.04
CY2014	exel	Percentage Of Employers Matching Contribution Towards To Retirement Plan PercentageOfEmployersMatchingContributionTowardsToRetirementPlan	0.03
CY2014Q4	exel	Percentageof Maximum Potential Milestone Payments Clinical Development PercentageofMaximumPotentialMilestonePaymentsClinicalDevelopment	0.10
CY2014Q4	exel	Percentageof Maximum Potential Milestone Payments Commercial PercentageofMaximumPotentialMilestonePaymentsCommercial	0.48
CY2014Q4	exel	Percentageof Maximum Potential Milestone Payments Regulatory PercentageofMaximumPotentialMilestonePaymentsRegulatory	0.42
CY2014Q4	exel	Percentofrevenuerecognizedonachievementofcontingency Percentofrevenuerecognizedonachievementofcontingency	1
CY2012Q3	exel	Proceeds From Convertible Debt Net ProceedsFromConvertibleDebtNet	277700000	USD
CY2012	exel	Proceeds From Exercise Of Stock Options And Warrants Net Of Repurchases ProceedsFromExerciseOfStockOptionsAndWarrantsNetOfRepurchases	929000	USD
CY2013	exel	Proceeds From Exercise Of Stock Options And Warrants Net Of Repurchases ProceedsFromExerciseOfStockOptionsAndWarrantsNetOfRepurchases	72000	USD
CY2014	exel	Proceeds From Exercise Of Stock Options And Warrants Net Of Repurchases ProceedsFromExerciseOfStockOptionsAndWarrantsNetOfRepurchases	120000	USD
CY2012Q3	exel	Proceeds From Issuance Of Common Stock And Convertible Debt Net ProceedsFromIssuanceOfCommonStockAndConvertibleDebtNet	416100000	USD
CY2012	exel	Research And Development Expenses Amount Of Reduction Relating To Prior Periods ResearchAndDevelopmentExpensesAmountOfReductionRelatingToPriorPeriods	2700000	USD
CY2013	exel	Research And Development Expenses Amount Of Reduction Relating To Prior Periods ResearchAndDevelopmentExpensesAmountOfReductionRelatingToPriorPeriods	800000	USD
CY2014	exel	Sales Revenue Percent Discount For Prompt Payment SalesRevenuePercentDiscountForPromptPayment	0.02
CY2012	exel	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expensed Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpensedFairValue	5600000	USD
CY2013	exel	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expensed Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpensedFairValue	7400000	USD
CY2014	exel	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expensed Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpensedFairValue	8600000	USD
CY2012	exel	Unrecognized Tax Benefits Increase Decrease Resultingfrom Prior Period Tax Positions UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromPriorPeriodTaxPositions	5894000	USD
CY2013	exel	Unrecognized Tax Benefits Increase Decrease Resultingfrom Prior Period Tax Positions UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromPriorPeriodTaxPositions	-112000	USD
CY2014	exel	Unrecognized Tax Benefits Increase Decrease Resultingfrom Prior Period Tax Positions UnrecognizedTaxBenefitsIncreaseDecreaseResultingfromPriorPeriodTaxPositions	719000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9345000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6413000	USD
CY2013Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	12797000	USD
CY2014Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	3350000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	34958000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	41545000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	45795000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-121000	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1564670000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1652400000	USD
CY2012Q3	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	4900000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	137785000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8781000	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12018000	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10006000	USD
CY2012	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	14752000	USD
CY2013	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	26290000	USD
CY2014	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	29534000	USD
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	72132000	shares
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	76965000	shares
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	105664000	shares
CY2013Q4	us-gaap	Assets Assets	503287000	USD
CY2014Q4	us-gaap	Assets Assets	327960000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	266609000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	167241000	USD
CY2013Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	409966000	USD
CY2014Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	238286000	USD
CY2013Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	409966000	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	238286000	USD
CY2013Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	300000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	145000	USD
CY2013Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	55000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	157000	USD
CY2013Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	409721000	USD
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	238298000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	82800000	USD
CY2014Q4	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	40	investment
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	74257000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	170069000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	103978000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	80395000	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	95812000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-66091000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-23583000	USD
CY2014Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	144300000	USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	184533651	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	195895769	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	184533651	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	195895769	shares
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	184000	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	196000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-147599000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-244522000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-268809000	USD
CY2013Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	68000	USD
CY2014Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	120000	USD
CY2013Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	10000000	USD
CY2014Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	98880000	USD
CY2013Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	255147000	USD
CY2014Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	182395000	USD
CY2012	us-gaap	Cost Of Goods Sold CostOfGoodsSold	0	USD
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1118000	USD
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2043000	USD
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	32000	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	107000	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	12000	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-182000	USD
CY2012	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	75000	USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	12000	USD
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-182000	USD
CY2012	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2013	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2014	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	2762000	USD
CY2012	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-106000	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-108000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1450000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2583000	USD
CY2012	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2000	USD
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	502000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	988000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	462394000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	550838000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	40968000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	39667000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	358372000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	446343000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	64635000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	64368000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	10107000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	6521000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	421426000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	511171000	USD
CY2014	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	16000000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	40968000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	39667000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	0	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Derivatives DeferredTaxLiabilitiesDerivatives	704000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	40968000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	38963000	USD
CY2012	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	600000	USD
CY2013	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	800000	USD
CY2014	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1100000	USD
CY2012	us-gaap	Depreciation Depreciation	4800000	USD
CY2013	us-gaap	Depreciation Depreciation	3100000	USD
CY2014	us-gaap	Depreciation Depreciation	2300000	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5513000	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3147000	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2391000	USD
CY2014Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	921000	USD
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.92
CY2013Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.24
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.34
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.36
CY2013Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.38
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.33
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.39
CY2014Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.38
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.32
CY2014Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.30
CY2014	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.38
CY2013	us-gaap	Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions	1500000	USD
CY2014	us-gaap	Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions	1600000	USD
CY2012	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2013	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2014	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1840000	USD
CY2014	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0	USD
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	500000	USD
CY2013Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	3691000	USD
CY2014Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	3701000	USD
CY2012	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2013	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2014	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	838000	USD
CY2012	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2014	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2013Q4	us-gaap	Goodwill Goodwill	63684000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	63684000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	9389000	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	11571000	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	5176000	USD
CY2013Q4	us-gaap	Gross Profit GrossProfit	4084000	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	4596000	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	6085000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	5718000	USD
CY2014Q4	us-gaap	Gross Profit GrossProfit	6669000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-34010000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-51295000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-55913000	USD
CY2013Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-59514000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-64988000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-61688000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-51574000	USD
CY2014Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-46208000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-147538000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-236076000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-237780000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-8780000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-30944000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-147538000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-244856000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-268724000	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	107000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-96000	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-182000	USD
CY2012	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-50163000	USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-83251000	USD
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-91366000	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	3297000	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	3380000	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	3598000	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	504000	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	393000	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	255000	USD
CY2012	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	39000	USD
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	58000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	65000	USD
CY2012	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	100000	USD
CY2012	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	74000	USD
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	10000	USD
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-182000	USD
CY2012	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	-32000	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	0	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	0	USD
CY2012	us-gaap	Income Taxes Paid IncomeTaxesPaid	1118000	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	60000	USD
CY2012	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-27038000	USD
CY2013	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	1190000	USD
CY2014	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	941000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5149000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8691000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-13213000	USD
CY2012	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1169000	USD
CY2013	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	14398000	USD
CY2014	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	6587000	USD
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-41920000	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-14871000	USD
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1133000	USD
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2890000	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-509000	USD
CY2012	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1966000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	USD
CY2014	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2149000	USD
CY2012	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1588000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1690000	USD
CY2014	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1427000	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1764000	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1034000	USD
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1526000	USD
CY2012	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-5499000	USD
CY2013	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-17268000	USD
CY2014	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-20354000	USD
CY2012	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	5244000	USD
CY2013	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-5750000	USD
CY2014	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-2302000	USD
CY2012	us-gaap	Interest Expense InterestExpense	27088000	USD
CY2013	us-gaap	Interest Expense InterestExpense	45347000	USD
CY2014	us-gaap	Interest Expense InterestExpense	48607000	USD
CY2012	us-gaap	Interest Paid InterestPaid	6982000	USD
CY2013	us-gaap	Interest Paid InterestPaid	19160000	USD
CY2014	us-gaap	Interest Paid InterestPaid	19109000	USD
CY2013Q4	us-gaap	Inventory Adjustments InventoryAdjustments	0	USD
CY2014Q4	us-gaap	Inventory Adjustments InventoryAdjustments	2141000	USD
CY2013Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	81000	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	559000	USD
CY2013Q4	us-gaap	Inventory Gross InventoryGross	2890000	USD
CY2014Q4	us-gaap	Inventory Gross InventoryGross	4522000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	2890000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	2381000	USD
CY2013Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	529000	USD
CY2014Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1118000	USD
CY2013Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2280000	USD
CY2014Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2845000	USD
CY2013	us-gaap	Inventory Write Down InventoryWriteDown	39000	USD
CY2014	us-gaap	Inventory Write Down InventoryWriteDown	200000	USD
CY2013Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	17031000	USD
CY2014Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	16364000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	437049000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	442789000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	503287000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	327960000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	87853000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	171860000	USD
CY2014Q4	us-gaap	Liabilities Fair Value Disclosure Recurring LiabilitiesFairValueDisclosureRecurring	921000	USD
CY2013Q4	us-gaap	Long Term Debt LongTermDebt	347237000	USD
CY2014Q4	us-gaap	Long Term Debt LongTermDebt	361656000	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	11762000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	99261000	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	0	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	104381000	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	287500000	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	80000000	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	335475000	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	262395000	USD
CY2013Q4	us-gaap	Long Term Investments LongTermInvestments	144299000	USD
CY2014Q4	us-gaap	Long Term Investments LongTermInvestments	81579000	USD
CY2013Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	80328000	USD
CY2014Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	80000000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	478428000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11669000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-123146000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-198773000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-235405000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-147645000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	65492000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-259470000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	144351000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	146330000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-44729000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-62161000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-67124000	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	-70746000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-244760000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-74619000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-73410000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-62560000	USD
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	-57953000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-268542000	USD
CY2012	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-25102000	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-44124000	USD
CY2014	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-44266000	USD
CY2013Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1762000	USD
CY2014Q4	us-gaap	Notes Payable Current NotesPayableCurrent	381000	USD
CY2014	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2012	us-gaap	Operating Expenses OperatingExpenses	169886000	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	232070000	USD
CY2014	us-gaap	Operating Expenses OperatingExpenses	249569000	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-122436000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-200732000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-224458000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	48493000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	20152000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals	9200000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2806000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	9104000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	16431000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	17800000	USD
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	9100000	USD
CY2014	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	10300000	USD
CY2012	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	3800000	USD
CY2013	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	4100000	USD
CY2014	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	4900000	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	13116000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	12282000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6888000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8340000	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	46000	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	238000	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-267000	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	106000	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4674000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4169000	USD
CY2012	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-4039000	USD
CY2013	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-6787000	USD
CY2014	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-4161000	USD
CY2012	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1986000	USD
CY2013	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1223000	USD
CY2014	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	4341000	USD
CY2012	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	533475000	USD
CY2013	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	189975000	USD
CY2014	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	119528000	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2717000	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2171000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	474000	USD
CY2012	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	41485000	USD
CY2013	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	6085000	USD
CY2014	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	8143000	USD
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5112000	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3481000	USD
CY2012	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2013	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2014	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	838000	USD
CY2012Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	65000000	USD
CY2012Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	138400000	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	75600000	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	203479000	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	75643000	USD
CY2012	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	277673000	USD
CY2013	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2014	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2012	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-4870000	USD
CY2013	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-13170000	USD
CY2014	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-11709000	USD
CY2012	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	310765000	USD
CY2013	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	325171000	USD
CY2014	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	252891000	USD
CY2012	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1943000	USD
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	143000	USD
CY2014	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	392000	USD
CY2012	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1217000	USD
CY2013	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1429000	USD
CY2014	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1438000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	50705000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	48702000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4910000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2432000	USD
CY2013Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	3941000	USD
CY2014Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	4882000	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	128878000	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	178763000	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	189101000	USD
CY2013Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	12213000	USD
CY2014Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	12212000	USD
CY2013Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	16897000	USD
CY2014Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	4684000	USD
CY2012	us-gaap	Restructuring Charges RestructuringCharges	9171000	USD
CY2013	us-gaap	Restructuring Charges RestructuringCharges	1231000	USD
CY2014	us-gaap	Restructuring Charges RestructuringCharges	7596000	USD
CY2013Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	4425000	USD
CY2014Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	6426000	USD
CY2013Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	9047000	USD
CY2014Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	4365000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1498762000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1767304000	USD
CY2012	us-gaap	Revenues Revenues	47450000	USD
CY2013	us-gaap	Revenues Revenues	31338000	USD
CY2014	us-gaap	Revenues Revenues	25111000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	40100000	USD
CY2012	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	0	USD
CY2013	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	15017000	USD
CY2014	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	25111000	USD
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	9669000	USD
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	11856000	USD
CY2013Q3	us-gaap	Sales Revenue Net SalesRevenueNet	5466000	USD
CY2013Q4	us-gaap	Sales Revenue Net SalesRevenueNet	4347000	USD
CY2014Q1	us-gaap	Sales Revenue Net SalesRevenueNet	4905000	USD
CY2014Q2	us-gaap	Sales Revenue Net SalesRevenueNet	6562000	USD
CY2014Q3	us-gaap	Sales Revenue Net SalesRevenueNet	6291000	USD
CY2014Q4	us-gaap	Sales Revenue Net SalesRevenueNet	7353000	USD
CY2012	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	31837000	USD
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	50958000	USD
CY2014	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	50829000	USD
CY2012Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	34500000	shares
CY2014	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P4Y2M15D
CY2013Q4	us-gaap	Short Term Investments ShortTermInvestments	138475000	USD
CY2014Q4	us-gaap	Short Term Investments ShortTermInvestments	63890000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	8833000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	12031000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	10006000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate	0.5
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	15403813	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.75
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1890185	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1066196	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1540215	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	358360	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	79942	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	4650543	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3442696	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	6694174	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	10038565	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	20000	USD
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	17436378	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	18448550	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	23983275	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	27811992	shares
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.16
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.85
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.48
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.00
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.09
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.06
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.28
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	7.54
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	6.45
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	8.06
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.88
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.27
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.34
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.45
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.44
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.11
CY2014Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	15403813	shares
CY2014Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	27811992	shares
CY2012Q1	us-gaap	Share Price SharePrice	5.17
CY2012Q3	us-gaap	Share Price SharePrice	4.25
CY2014Q1	us-gaap	Share Price SharePrice	8
CY2014Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y6M25D
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y2M15D
CY2014Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	6.75
CY2014Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	5.00
CY2012Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	12700000	shares
CY2014Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	10000000	shares
CY2012	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	181979	shares
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	13311	shares
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	19090	shares
CY2012	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	203961000	USD
CY2014	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	75643000	USD
CY2012	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2822000	USD
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2295000	USD
CY2014	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2093000	USD
CY2011Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	90632000	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	296434000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	66238000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-114829000	USD
CY2012	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	300000	USD
CY2013	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	100000	USD
CY2014	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	700000	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	39310000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	47298000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	55077000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	58215000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2094000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	7891000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2706000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	15000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	20000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	6000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	4000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2013	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2014	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	287000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	100000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	100000	USD
CY2012	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6800000	USD
CY2013	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-16800000	USD
CY2014	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-89700000	USD
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	160138000	shares
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	184062000	shares
CY2014	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	194299000	shares
CY2014	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of our consolidated financial statements is in conformity with accounting principles generally accepted in the United States which requires management to make judgments. The preparation of our consolidated financial statements is in conformity with accounting principles generally accepted in the United States which requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures. On an ongoing basis, management evaluates its estimates including, but not limited to, those related to revenue recognition, including for deductions from revenues (such as rebates, chargebacks, sales returns and sales allowances), recoverability of inventory, certain accrued liabilities including clinical trial accruals and restructuring liabilities, the valuation of the debt and equity components of our convertible debt at issuance, valuation of warrants, and share-based compensation. We base our estimates on historical experience and on various other market-specific and other relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. </font><font style="font-family:inherit;font-size:10pt;">Actual results could differ materially from those estimates.</font></div><div style="line-height:120%;padding-top:18px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font></div></div>

Files In Submission

Name	View Source	Status
0000939767-15-000013-index-headers.html	Edgar Link	pending
0000939767-15-000013-index.html	Edgar Link	pending
0000939767-15-000013.txt	Edgar Link	pending
0000939767-15-000013-xbrl.zip	Edgar Link	pending
exel-20141231.xml	Edgar Link	completed
exel-20141231.xsd	Edgar Link	pending
exel-20141231_cal.xml	Edgar Link	unprocessable
exel-20141231_def.xml	Edgar Link	unprocessable
exel-20141231_lab.xml	Edgar Link	unprocessable
exel-20141231_pre.xml	Edgar Link	unprocessable
exel2014123110-k.htm	Edgar Link	pending
exel20141231exhibit121.htm	Edgar Link	pending
exel20141231exhibit211.htm	Edgar Link	pending
exel20141231exhibit231.htm	Edgar Link	pending
exel20141231exhibit311.htm	Edgar Link	pending
exel20141231exhibit312.htm	Edgar Link	pending
exel20141231exhibit321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fiveyearchart2014.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EXEL
EXELIXIS, INC. Stock $exel

2015 Q1 Form 10-K Financial Statement

#000093976715000013 Filed on March 02, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXEL EXELIXIS, INC. Stock $exel

2015 Q1 Form 10-K Financial Statement

#000093976715000013 Filed on March 02, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EXEL
EXELIXIS, INC. Stock $exel